Morgan Stanley’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-418,255
Closed -$1.42M 6892
2018
Q3
$1.42M Sell
418,255
-746,166
-64% -$2.54M ﹤0.01% 4267
2018
Q2
$4.38M Buy
1,164,421
+771,315
+196% +$2.9M ﹤0.01% 3301
2018
Q1
$1.61M Buy
393,106
+27,958
+8% +$114K ﹤0.01% 4196
2017
Q4
$1.7M Sell
365,148
-81,586
-18% -$379K ﹤0.01% 4169
2017
Q3
$3.17M Buy
446,734
+80,735
+22% +$573K ﹤0.01% 3431
2017
Q2
$2.65M Sell
365,999
-65,182
-15% -$471K ﹤0.01% 3535
2017
Q1
$2.66M Sell
431,181
-25,919
-6% -$160K ﹤0.01% 3548
2016
Q4
$2.68M Buy
457,100
+302,403
+195% +$1.77M ﹤0.01% 3653
2016
Q3
$821K Sell
154,697
-83,233
-35% -$442K ﹤0.01% 4176
2016
Q2
$1.58M Buy
237,930
+120,261
+102% +$796K ﹤0.01% 3619
2016
Q1
$550K Sell
117,669
-51,586
-30% -$241K ﹤0.01% 4378
2015
Q4
$854K Buy
169,255
+16,976
+11% +$85.7K ﹤0.01% 4178
2015
Q3
$536K Sell
152,279
-39,836
-21% -$140K ﹤0.01% 4562
2015
Q2
$1.92M Buy
192,115
+5,100
+3% +$50.9K ﹤0.01% 3672
2015
Q1
$2.38M Sell
187,015
-85,670
-31% -$1.09M ﹤0.01% 3437
2014
Q4
$3.86M Sell
272,685
-165,912
-38% -$2.35M ﹤0.01% 2970
2014
Q3
$6.03M Buy
438,597
+212,737
+94% +$2.93M ﹤0.01% 2472
2014
Q2
$3.47M Buy
225,860
+45,333
+25% +$697K ﹤0.01% 3014
2014
Q1
$3.08M Buy
180,527
+48,198
+36% +$821K ﹤0.01% 3054
2013
Q4
$1.71M Buy
132,329
+6,973
+6% +$90.3K ﹤0.01% 3493
2013
Q3
$1.27M Sell
125,356
-10,421
-8% -$105K ﹤0.01% 3594
2013
Q2
$1.01M Buy
+135,777
New +$1.01M ﹤0.01% 3718